JAGSNPHARMBSEJagsonpal Pharmaceuticals LtdHighNegative
Announced Mon, 18 May · 17:52 IST

Resignation of an Independent Director.

Management Changes View source PDF

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹198.94
prior close
₹201.07
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2-0.5-1.5-1.3+0.1+6.6+5.1+3.9+4.1+3.5+3.0+7.1+12.1
Up moveDown movePending
AI summary

Mrs. Pallavi Dinodia Gupta has resigned as Independent Director of Jagsonpal Pharmaceuticals Ltd effective May 18, 2026, citing personal reasons including increasing professional commitments, personal engagements, and health considerations. With this resignation, she also ceases to be a member of the Audit Committee, Corporate Social Responsibility Committee, and Chairperson of the Stakeholders Relationship Committee. The company has stated that her detailed resignation letter will be filed separately. The director confirmed there are no material reasons for her resignation other than those stated. She holds independent directorships in three other listed companies: IndiaMART InterMESH Limited, Voith Paper Fabrics India Limited, and Lumax Industries Limited.

Likely market impact

The departure reduces the board's independent oversight, particularly affecting three key committees. Investors should monitor the company's timely appointment of a replacement independent director to maintain proper governance structure and committee composition.